Why the study?
The study aimed to describe the current practice and results of genetic evaluation in Dutch children with dilated cardiomyopathy and evaluate genotype-phenotype correlations that may guide prognosis.
Key points are not available for this paper at this time.
Population
Children diagnosed with dilated cardiomyopathy from 2010 to 2017
Design
Multicenter observational study
Answers are grounded in this paper and cite their sources.
Genetic testing may aid prognostic stratification in pediatric dilated cardiomyopathy; hypothesis-generating for genotype-phenotype correlations.
BACKGROUND: This study aimed to describe the current practice and results of genetic evaluation in Dutch children with dilated cardiomyopathy and to evaluate genotype-phenotype correlations that may guide prognosis. METHODS: We performed a multicenter observational study in children diagnosed with dilated cardiomyopathy, from 2010 to 2017. Clinical characteristics at diagnosis did not differ between the 2 groups. CONCLUSIONS: Genetic testing is a valuable tool for predicting prognosis in children with dilated cardiomyopathy, with carriers of a likely pathogenic or pathogenic variant having a worse prognosis overall. Genetic testing should be incorporated in clinical work-up of all children with dilated cardiomyopathy regardless of presumed disease pathogenesis.
No takes yet. Share an insight, caveat, or question.
Meulen et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: